Maravai Lifesciences Holdings (MRVI) Raw Materials (2020 - 2026)

Maravai Lifesciences Holdings' Raw Materials history runs 7 years deep, the most recent figure standing at $12.8 million for Q1 2026.

• On a quarterly basis, Raw Materials fell 25.32% year-over-year to $12.8 million in Q1 2026; TTM through Mar 2026 was $12.8 million, a 25.32% decrease from a year earlier, with the FY2025 full-year figure at $14.6 million, down 13.95% from the prior year.
• Raw Materials eased to $12.8 million in Q1 2026 per MRVI's latest filing, from $14.6 million in the prior quarter.
• Across five years, Raw Materials topped out at $26.8 million in Q3 2023 and bottomed at $12.8 million in Q1 2026.
• The 5-year median for Raw Materials is $17.2 million (2025), against an average of $18.3 million.
• Across the five-year window, Raw Materials jumped 43.39% in 2023 and slumped 37.79% in 2024, its largest moves.
• Year by year, Raw Materials stood at $13.5 million in 2022, then jumped by 43.39% to $19.3 million in 2023, then declined by 12.22% to $17.0 million in 2024, then retreated by 13.95% to $14.6 million in 2025, then decreased by 12.02% to $12.8 million in 2026.
• Per Business Quant, the three latest MRVI Raw Materials figures stand at $12.8 million (Q1 2026), $14.6 million (Q4 2025), and $16.0 million (Q3 2025).